THU-166-Treatment of 320 genotype 3 cirrhotic patients with 12 weeks of sofosbuvir/velpatasvir with or without ribavirin: Real life experience from ItalyL. Pasulo, Antonio Albanese, V. Di Marco et al.|Journal of Hepatology|2019Cited by 1
THU-141-Efficacy and safety of elbasvir/grazoprevir in a large real-life cohort of HCV-infected patientsMartina Gambato, Marie Graciella Pigozzi, Angiola Spinetti et al.|Journal of Hepatology|2019Cited by 1
THU-128-Renal safety in 3,264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life studyRoberta D’Ambrosio, S. Fagiuoli, L. Pasulo et al.|Journal of Hepatology|2019Cited by 0